View Older Stories

Jun 23, 2026 07:24AM Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald on Negative SV Data

Jun 18, 2026 01:24PM Pfizer reafffirms 2026 guidance after CFO transition announcement

Jun 18, 2026 01:18PM Pfizer reaffirms 2026 guidance after CFO transition news

Jun 16, 2026 04:33PM Arvinas and Pfizer complete Rigel license deal for vepdegestrant

Jun 15, 2026 06:08AM German government to drop variable drug discounting plans - Reuters

Jun 10, 2026 02:29AM RBC Capital Upgrades Pfizer (PFE) to Sector Perform

Jun 4, 2026 07:00PM ADA 2026 preview: All eyes on these 2 stocks

Jun 1, 2026 08:02AM Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald

Jun 1, 2026 02:54AM Pfizer drug combination cuts prostate cancer progression risk by 52%

Jun 1, 2026 02:53AM Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer

May 29, 2026 12:07PM Morgan Stanley: China healthcare sector dips 1.3% amid licensing scrutiny

May 29, 2026 08:02AM Pfizer's LORBRENA shows 55% seven-year survival without progression

May 27, 2026 09:46AM UBS Reiterates Neutral Rating on Pfizer (PFE)

May 13, 2026 02:53PM Arvinas Inc. (ARVN) PT Raised to $16 at BofA Securities

May 13, 2026 06:45AM European Commission approves Pfizer's HYMPAVZI for hemophilia with inhibitors

May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico

May 12, 2026 07:01AM Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront

May 12, 2026 05:37AM MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update

May 11, 2026 10:23AM HHS downplays Hantavirus risk amid repatriation efforts

May 8, 2026 12:04PM Health officials explore restrictions on certain SSRI antidepressants - Reuters

May 7, 2026 02:15PM Novo Nordisk Eyes Large-Scale M&A Following Pfizer's Metsera Win - Semafor

May 5, 2026 03:11PM Pfizer (PFE) PT Raised to $27 at BofA Securities

May 5, 2026 02:11PM Pfizer Reviewing New Molecule It Designed Using AI - CEO

May 5, 2026 07:17AM Pfizer beats first quarter estimates on strong product growth

May 5, 2026 06:46AM Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance

May 4, 2026 11:18AM Pfizer (PFE) call put ratio 4.7 calls to 1 put quarter results

May 4, 2026 05:38AM Pfizer (PFE) calls more active than puts into quarter results

May 1, 2026 10:50AM Pfizer (PFE) call put ratio 2.9 calls to 1 put with a focus on May 8 weekly 27 calls into quarter results

Apr 29, 2026 06:45AM Pfizer's ELREXFIO meets primary endpoint in multiple myeloma trial

Apr 28, 2026 02:00PM Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'

Apr 28, 2026 12:14PM Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'

Apr 28, 2026 11:46AM TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'

Apr 28, 2026 11:41AM RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'

Apr 28, 2026 11:25AM Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'

Apr 28, 2026 10:53AM Morgan Stanley on Pfizer (PFE): 'we believe generic versions of Vyndaqel could still represent a potential headwind to the franchise'

Apr 28, 2026 10:17AM Pfizer extends VYNDAMAX patent protection to 2031 through settlements

Apr 28, 2026 09:48AM Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'

Apr 28, 2026 09:46AM RBC on Pfizer (PFE): 'Litigation overhang cleared'

Apr 28, 2026 09:38AM Barclays: 'We think dropping the question of '441 validity from the case is a major development'

Apr 24, 2026 06:59AM Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs

Apr 15, 2026 06:14AM CICC Starts Pfizer (PFE) at Outperform

Apr 13, 2026 09:51AM Pfizer (PFE) PT Raised to $27 at UBS

Apr 13, 2026 06:58AM Guggenheim Reiterates Buy Rating on Pfizer (PFE)

Apr 9, 2026 09:24AM Pfizer (PFE) PT Lowered to $26 at BofA Securities

Apr 7, 2026 08:54AM RBC Capital Reiterates Underperform Rating on Pfizer (PFE)

Apr 1, 2026 03:01PM Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'

Mar 31, 2026 01:10PM Pfizer (PFE) to shutter South S.F. research site, end Bay Area presence - Bloomberg

Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'

Mar 24, 2026 06:31AM Pfizer (PFE) PT Raised to $36 at Guggenheim

Mar 20, 2026 04:30PM Pfizer advises shareholders to reject Tutanota mini-tender offer

View Older Stories